Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

UserTweets
@gcassidy718 6
@AmericanBanking 3
@ThisLincolnian 2
@WeekHerald 2
@BlueBioNow 2

Recent Tweets for BCRX

bio_econ @bio_econ
@ag76_biotech ~ baker bros. have missed plenty of times. see $BCRX
October 21st 2019, 10:10am
BlueBioNow @BlueBioNow
$BCRX significant stock price movement -4.80 % change recently https://t.co/hAe9zuMfLj
October 21st 2019, 1:10am
WeekHerald @WeekHerald
Brokerages Set BioCryst Pharmaceuticals, Inc. $BCRX Target Price at $9.10 https://t.co/idZ2En54iW
October 20th 2019, 10:10am
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals, Inc. $BCRX Receives $9.10 Average Price Target from Analysts https://t.co/mY0ZN87Qsa
October 20th 2019, 10:10am
BlueBioNow @BlueBioNow
$BCRX exactly don't sell -4.80 % change recently https://t.co/hAe9zuMfLj
October 19th 2019, 11:10pm
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.31 Per Share https://t.co/IHWeBXsl87
October 18th 2019, 5:10pm
dispatchtribune @dispatchtribune
-$0.31 EPS Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/d88KbwkjN0
October 18th 2019, 5:10pm
WeekHerald @WeekHerald
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Quarterly Sales of $4.54 Million https://t.co/oJ3NaxcRiy
October 18th 2019, 4:10pm
ThisLincolnian @ThisLincolnian
Brokerages Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Post Quarterly Sales of $4.54 Million https://t.co/z2L92NwugX
October 18th 2019, 4:10pm
gcassidy718 @gcassidy718
$BCRX a bit volatility -3.80 % change recently https://t.co/7WiofvNfOn
October 18th 2019, 3:10pm
ChartMill @ChartMill
$BCRX's ROE of 1367.48% is amongst the best returns of the industry https://t.co/nJ4VuCEtG0 https://t.co/yARE8tUTlI
October 18th 2019, 2:10pm
TickerReport @TickerReport
BioCryst Pharmaceuticals, Inc. $BCRX Given Average Recommendation of “Hold” by Analysts https://t.co/uiVu52Uw51
October 17th 2019, 12:10pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Given Average Recommendation of “Hold” by Analysts https://t.co/GWTv4R6H9p #stocks
October 17th 2019, 11:10am
dailypoliticaln @dailypoliticaln
BioCryst Pharmaceuticals, Inc. $BCRX Given Average Rating of “Hold” by Brokerages https://t.co/MN4SoMy3AH
October 17th 2019, 11:10am
ZolmaxNews @ZolmaxNews
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.31 Per Share https://t.co/mCahYExgwa
October 16th 2019, 12:10pm
gcassidy718 @gcassidy718
$BCRX substantial stock price changes 5.20 % change recently https://t.co/7WiofvNfOn
October 16th 2019, 11:10am
gcassidy718 @gcassidy718
$BCRX stock is up 2.66 % with an ok PE -2.17 and beta 1.41 https://t.co/7WiofvNfOn
October 14th 2019, 3:10pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Announce Quarterly Sales of $4.54 Million https://t.co/ulzt1yjlYM #stocks
October 13th 2019, 1:10am
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.31 Per Share https://t.co/cPnZ7kj608 #stocks
October 11th 2019, 11:10pm
gcassidy718 @gcassidy718
$BCRX Long and strong 2.92 % https://t.co/7WiofvNfOn
October 11th 2019, 9:10pm
gcassidy718 @gcassidy718
$BCRX My valuations is at $2.73. Waiting for it to come down. https://t.co/7WiofvNfOn
October 10th 2019, 12:10pm
gcassidy718 @gcassidy718
$BCRX Valuation is starting to make more sense now $2.25. https://t.co/7WiofvNfOn
October 8th 2019, 3:10pm
ez_scans @ez_scans
$BCRX (( o3_yrlo ))=52 week low
October 8th 2019, 10:10am
macondailynews @macondailynews
BioCryst Pharmaceuticals $BCRX Upgraded to “Buy” by ValuEngine https://t.co/yTjDNc9skr
October 8th 2019, 2:10am
TheMarketsDaily @TheMarketsDaily
BioCryst Pharmaceuticals $BCRX Upgraded to “Buy” by ValuEngine https://t.co/6roQ98VHUw
October 8th 2019, 2:10am
StockNewsWires @StockNewsWires
$BCRX: BioCryst: Much At Stake In Next Phase I Results Of BCX9930: https://t.co/UYTOvRX6gV
October 7th 2019, 9:10am
SeekingAlpha @SeekingAlpha
$BCRX - BioCryst: Much At Stake In Next Phase I Results Of BCX9930. Follow this and any other stock on Seeking Alph… https://t.co/AjSOahQnMm
October 7th 2019, 9:10am
DataTrials @DataTrials
$BCRX Phase 3 Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE A… https://t.co/YIoQt9p1pe
October 7th 2019, 6:10am
debgkatz @debgkatz
$bcrx at 2.7 - having trouble getting thru 2.75-2.77 area . Has potential to get back to 3.6-3.7 but it would be a… https://t.co/u0jARISxCu
October 7th 2019, 2:10am
dakotafinancial @dakotafinancial
BioCryst Pharmaceuticals $BCRX Upgraded to “Buy” by ValuEngine https://t.co/Yl1MZuajUb
October 6th 2019, 11:10pm
dispatchtribune @dispatchtribune
ValuEngine Upgrades BioCryst Pharmaceuticals $BCRX to “Buy” https://t.co/GUHfa06MJI
October 6th 2019, 11:10pm
ThisLincolnian @ThisLincolnian
ValuEngine Upgrades BioCryst Pharmaceuticals $BCRX to “Buy” https://t.co/3gEyFSZkn7
October 6th 2019, 4:10pm
TickerReport @TickerReport
BioCryst Pharmaceuticals $BCRX Rating Lowered to Strong Sell at BidaskClub https://t.co/5ioC9RPIwX
October 6th 2019, 1:10pm
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Rating Lowered to Strong Sell at BidaskClub https://t.co/GfOzPbekl9
October 6th 2019, 12:10pm
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals $BCRX Rating Lowered to Strong Sell at BidaskClub https://t.co/wbVrBQyXFH
October 6th 2019, 10:10am
registrarjourn @registrarjourn
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub to “Strong Sell” https://t.co/9VoTJhEMqG
October 6th 2019, 10:10am
EnterpriseLeade @EnterpriseLeade
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub to “Strong Sell” https://t.co/rY3PsmWTvB
October 6th 2019, 10:10am
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub to “Strong Sell” https://t.co/UTfwdEoikR
October 5th 2019, 8:10pm
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Upgraded to “Buy” at ValuEngine https://t.co/RIEg9CVbSa
October 5th 2019, 4:10pm
ConsumerFeed @ConsumerFeed
BioCryst Pharmaceuticals $BCRX Stock Rating Lowered by BidaskClub https://t.co/lwzuE756h5
October 4th 2019, 11:10am
IRAMarketReport @IRAMarketReport
BioCryst Pharmaceuticals $BCRX Stock Rating Lowered by BidaskClub https://t.co/Vs7owTtOjx #markets
October 4th 2019, 11:10am
chaffeybreeze @chaffeybreeze
BioCryst Pharmaceuticals $BCRX Stock Rating Lowered by BidaskClub https://t.co/q4HtrGNbUq #stocks
October 4th 2019, 11:10am
botpicks @botpicks
Should I Go Long or Short $BCRX ?
October 4th 2019, 2:10am
ChartMill @ChartMill
$BCRX's ROE of 1367.48% is amongst the best returns of the industry https://t.co/nJ4VuCEtG0 https://t.co/b0hletRai1
October 4th 2019, 12:10am
StockNewsNow @StockNewsNow
$BCRX BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://t.co/8QqHRWqKmF
October 3rd 2019, 11:10am
VisualStockRSRC @VisualStockRSRC
$BCRX - BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://t.co/3BLZKUUhIn
October 3rd 2019, 7:10am
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Stock Price Down 9.8% https://t.co/LNpEB4wzbQ
October 3rd 2019, 2:10am
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Stock Price Down 9.8% https://t.co/DQvSEb8k6Q
October 3rd 2019, 2:10am
WeekHerald @WeekHerald
BioCryst Pharmaceuticals $BCRX Shares Down 9.8% https://t.co/0j3mdCRwdv
October 3rd 2019, 2:10am
dakotafinancial @dakotafinancial
BioCryst Pharmaceuticals $BCRX Stock Price Down 9.8% https://t.co/g7DeManSZv
September 30th 2019, 9:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.